BMA (BMA) Institutional Ownership
None of the superinvestors we track currently report BMA in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in BMA, this page will show fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q2 2025 | 1 | $4,254,094 | 60,591 |
| Q1 2025 | 1 | $19,667,485 | 260,462 |
| Q4 2024 | 1 | $36,635,755 | 378,625 |
| Q3 2024 | 1 | $29,483,050 | 464,300 |
| Q2 2024 | 1 | $26,618,319 | 464,300 |
| Q1 2024 | 1 | $20,924,574 | 434,300 |
| Q4 2023 | 1 | $1,372 | 47,800 |
| Q3 2023 | 1 | $1,308 | 66,300 |
| Q2 2023 | 1 | $2,364 | 89,595 |
| Q1 2023 | 1 | $1,036 | 58,178 |
| Q4 2022 | 1 | $335 | 20,400 |
| Q3 2022 | 1 | $792 | 55,472 |
Related BMA Institutional Insights:
- BMA Institutional Ownership & Insiders Activity
- BMA Institutional Ownership & 13F Activity
- BMA Top Institutional Shareholders
- BMA Institutional Buying Activity
- BMA Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- BMA Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings